Haisco Pharmaceutical Group Co., Ltd. at its 2nd Extraordinary General Meeting of 2023 on 25 August 2023, during which the following proposal(s) was/were approved: Election and nomination of non-independent directors, cumulative voting system applicable: Wang Junmin, Fan Xiulian, Zheng Wei, Yan Pangke. Election and nomination of independent directors, cumulative voting system applicable: Yue Lin and Cao Chuande. Election of shareholder supervisors, cumulative voting system applicable: Liang Yuan and Sun Tao.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.63 CNY | -0.58% | +0.89% | +32.31% |
04-19 | Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04-18 | Haisco Pharmaceutical Gets Nod to Trial HSK16149 Capsules | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.31% | 4.68B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 002653 Stock
- News Haisco Pharmaceutical Group Co., Ltd.
- Haisco Pharmaceutical Group Co., Ltd. Announces Management Changes